AVBP — ArriVent BioPharma, Inc. | XLV Holdings | StockAdder

(AVBP)

ArriVent BioPharma, Inc.

Live chart and latest AVBP stock news.

Sector ETF → XLV Health Care Select

Chart powered byTradingView— professional charts for every trader.Try it free →

AVBP News

Are medical stocks lagging ArriVent BioPharma, Inc. (AVBP) this year?

Apr 15, 2026 Seeking Alpha

ArriVent BioPharma: Phase 3 Delay May Signal Stronger Outcomes For Firmonertinib (NASDAQ:AVBP)

Mar 24, 2026 Sahm

A Look At ArriVent BioPharma (AVBP) Valuation As Shares Show Renewed Momentum

Apr 4, 2026 Bitget

Wall Street experts predict that ArriVent BioPharma, Inc. (AVBP) may climb by 72.44%. Check this out before making any investment decisions.

Apr 5, 2026 Yahoo Finance

Is ArriVent BioPharma, Inc. (AVBP) Stock Outpacing Its Medical Peers This Year?

Mar 10, 2026 Stock Titan

ArriVent BioPharma (NASDAQ: AVBP) widens 2025 loss as R&D spend climbs

Mar 5, 2026 MSN

Wall Street analysts think ArriVent BioPharma, Inc. (AVBP) could surge 72.44%: Read this before placing a bet

Apr 14, 2026 simplywall.st

Here's Why We're Watching ArriVent BioPharma's (NASDAQ:AVBP) Cash Burn Situation

Nov 13, 2025 Intellectia AI

AVBP Technical Analysis & Stock Price Forecast

Apr 4, 2026 TipRanks

ArriVent Highlights Next-Generation Oncology Data at AACR 2026

Mar 17, 2026 Seeking Alpha

ArriVent BioPharma: Its Leading Asset, Furmonertinib, Supports A Cautious Buy

Jan 4, 2026 Stock Titan

Lung and ovarian cancer drug data from ArriVent to debut at 2026 AACR

Mar 17, 2026 Seeking Alpha

ArriVent BioPharma: A De-Risked Binary With Near-Term Catalysts (NASDAQ:AVBP)

Dec 25, 2025 Yahoo Finance

Assessing ArriVent BioPharma (AVBP) Valuation After Recent Share Price Momentum And Pipeline Interest

Apr 4, 2026 Stock Titan

AVBP Stock Price, News & Analysis